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Matrix metalloproteinase-9 (MMP-9) plays an important role in the acute periods of spinal cord injury (SCI), and its expression is
related to the inﬂammation which could cause the disruption of the blood-spinal barrier (BBB). Nuclear factor erythroid 2-related
factor 2 (Nrf2) is a key transcription factor that plays a crucial role in cytoprotection against inﬂammation. The present study
investigated the role of Nrf2 in upregulating of nuclear factor kappa B (NF-κB) activity, tumor necrosis factor-α (TNF-α), and
MMP-9 after SCI. Wild-type Nrf2 (+/+) and Nrf2-deﬁcient (Nrf (−/−)) mice were subjected to an SCI model induced by the
application of vascular clips (force of 10g) to the dura after a three-level T8-T10 laminectomy. We detected the wet/dry weight
ratio of impaired spinal cord tissue, the activation of NF-κB, the mRNA and protein levels of TNF-α and MMP-9, and the enzyme
activity of MMP-9. Nrf2 (−/−) mice were demonstrated to have more spinal cord edema, NF-κB activation, TNF-α production,
and MMP-9 expression after SCI compared with the wild-type controls. The results suggest that Nrf2 may play an important role
in limiting the upregulation of NF-κBa c t i v i t y ,T N F - α, and MMP-9 in spinal cord after SCI.
1.Introduction
Spinal cord injury (SCI) initiates a series of cellular and
molecular cascade events and that a combination of sec-
ondary injury factors leads to a progressive neuronal injury
[1]. It is generally accepted that, among the secondary injury
factors, inﬂammation is the major one and plays a central
role in regulating the pathogenesis of SCI [2, 3]. Attenuation
of the early inﬂammatory response after SCI may limit the
extent of tissue injury and the consequent disability [4–6].
The proinﬂammatory cytokine TNF-α, which is upregulated
immediately after SCI, can enhance vascular permeability
[7]. Hence, TNF-α is considered as a proinﬂammatory cyto-
toxic cytokine. And TNF-α is primarily responsible for initi-
ating the cascade of other cytokines in the classic immune
response [6, 8]. Inﬂammatory cells can release matrix
metalloproteinases (MMPs), especially MMP-9, which can
penetrate the BBB [9]. MMP-9 is upregulated in leucocytes
entering the spinal cord, directly facilitating their extrava-
sation, and promoting the tissue damage that they caused
[9, 10]. It might be a vascular permeabilizing factor and is
a key determinant in secondary tissue damage after SCI.
Nuclear factor erythroid 2-related factor 2 (Nrf2), a
leucine zipper redox-sensitive transcription factor, is a
pleiotropicregulatorofcellsurvivalmechanisms[11].Under
the normal condition, Nrf2 is sequestered in the cytoplasm
by a cytosolic regulatory protein named Keap1. Under
condition of oxidative or xenobiotic stress, Nrf2 translocates
from the cytoplasm to the nucleus and sequentially binds
to a promoter sequence called the antioxidant response
element(ARE),resultingintheexpressionofantioxidantand
cytoprotective genes that attenuate tissue injury [12–14].
Recent studies have demonstrated that Nrf2 plays a
broad role in modulating acute inﬂammatory response.
Nrf2 plays a protective role in cigarette smoke-induced
emphysema [15], dextran sulfate sodium- (DSS-) mediated
colitis [16], inﬂammation-mediated colonic tumorigenesis
[17], and allergen-mediated airway inﬂammation [18]. Our
previous studies have shown that Nrf2 played an important
role in protecting traumatic brain injury- (TBI-) induced2 Mediators of Inﬂammation
secondarybraininjurybyregulatinginﬂammatorycytokines
and attenuating the pulmonary inﬂammatory response and
NF-κBa c t i v a t i o na f t e rT B I[ 12, 19].
We have found that SCI could induce the activation of
Nrf2-ARE pathway in spinal cord tissue (data not shown),
just as Pomeshchik et al. showed [20]. Therefore, it is
reasonable to postulate that Nrf2 plays an important role in
limiting the spinal cord inﬂammatory response after SCI. In
thepresentstudy,weevaluatedtheeﬀectofNrf2genotypeon
the activation of NF-κB, TNF-α, and MMP-9 in spinal cord
after SCI.
2.MaterialsandMethods
2.1.Animals. OurexperimentswereconformedtotheGuide
for the Care and Use of Laboratory Animals by National
Institutes of Health (NIH Publications no. 80-23) and
approved by the Animal Care and Use Committee of Nanjing
University. Male ICR mice (28–32g) were housed at 23 ±
1◦C in humidity-controlled animal quarters with 12 hours
light/darkcycle,andwithadlibitumaccesstofoodandwater
throughout the study. Breeding pairs of Nrf2-decient ICR
mice were kindly provided by Dr. Thomas W. Kensler (Johns
Hopkins University, Baltimore, Md, USA). Homozygous
wild-type Nrf2 (+/+) and Nrf2 (−/−)-deﬁcient mice were
generated from inbred heterozygous Nrf2 (+/−)m i c e[ 14].
Genotypes of Nrf2 (+/+) and Nrf2 (−/−)m i c ew e r ec o n -
ﬁrmed by PCR ampliﬁcation of genomic DNA isolated from
the blood. PCR ampliﬁcation was carried out by using three
diﬀerent primers, 5 - TGGACGGGACTATTGAAGGCTG-3 
(sense for both genotypes), 5 -CGCCTTTTCAGTAGAT-
GGAGG-3  (antisense for wild type), and 5 -GCGGATTGA-
CCGTAATGGGATAGG-3  (antisense for LacZ). Age- and
weight-matched adult male mice (6–8 weeks, 28–32g) were
separated into four groups (n = 42 per group): group
I, sham wild-type (Nrf2 +/+); group II, injured wild-type
(Nrf2 +/+); group III, sham-deﬁcient (Nrf2 −/−); group
IV, injured-deﬁcient (Nrf2 −/−) .T h em i c eo fs h a ma n d
injured groups were subjected to identical anesthetic alone
or experimental SCI, respectively.
2.2. Experiment Protocol. The mouse compression model of
SCI established as described previously used to study spinal
cord injury in mice [21]. Brieﬂy, the animals were anes-
thetized with sodium pentobarbital (50mg/kg, ip). A longi-
tudinal skin incision was made to expose the spine between
T8 and T10 vertebral body levels, and the paravertebral mus-
cles of the thoracic-level (T8–T10) vertebrae were removed.
Laminectomy was performed at the T8–T10 level, using
an operating microscope (M500-N, LAICA, Germany). In
sham-operated mice, the muscles and skin wound was then
closed. In order to cause an acute-compression injury, we
used a vascular clip (with 10g force, Kent Scientiﬁc Corpo-
ration, INS 14120, USA) to injure the cord at T9 by bilateral
compression for 1 minute. After surgery, the animals were
given a subcutaneous saline injection (1-2mL) immediately.
They were left to recover on a warm pad until thermoregu-
lation and the righting reﬂex was re-established. Then they
were returned to their cages with free food and water. The
rectaltemperaturewasmonitoredandwaskeptat37 ±0.5◦C
(with physical cooling if required) throughout the experi-
ment.Asdescribed,animalsreceivedmanualbladderexpres-
sion twice daily until urinary retention was relieved [1].
At 24 hours following sham operation or SCI, thirty
mice in each group were sacriﬁced for spinal cord segments
collection to assay NF-κBa c t i v i t y ,T N F - α,a n dM M P - 9 .
Brieﬂy, mice were deeply anaesthetized with pentobarbital
sodium (80mg/kg) and were transcardially perfused with
cold saline (4◦C), and then the tissue segments containing
the lesion (1cm on each side of the lesion) were rapidly
removed and stored at liquid nitrogen immediately. Six mice
of each group were sacriﬁced at 48 hours after operation
for assays of spinal cord water content of spinal cord
segments. The last six mice in each group were evaluated
by histopathology at 24 hours after SCI. They were perfused
with cold saline (4◦C), followed by 4% neutral-buﬀered
formalin. Spinal cord segments containing the lesion (0.5cm
on each side of the lesion) were taken, stored overnight in
4% neutral-buﬀered formalin, then were paraﬃne m b e d d e d ,
and cut into 5μm-thick sections. Tissue sections (thickness
5μm) were deparaﬃnized with xylene, stained with Hema-
toxylin/Eosin (H&E), and studied using light microscopy
(ECLIPSE E100, Nikon, Japan).
2.3. Spinal Cord Water Content. The spinal cord water
content was measured as previously described [22]. At 48
hours after SCI, spinal cords were removed from T7 to T11
vertebral body levels, weighed, heated at 98◦C for 48 hours,
and reweighed. Percent water content was calculated as [(wet
weight – dry weight)/wet weight].
2.4. Light Microscopy. The segments of each spinal cord
tissue were evaluated by an experienced histopathologist.
Damaged neurons were counted and the histopathologic
changes of the gray matter were scored on a 6-point scale
[23,24]: (0),no lesion observed; (1), gray mattercontained 1
to 5 eosinophilic neurons; (2), gray matter contained 5 to 10
eosinophilic neurons; (3), gray matter contained more than
10 eosinophilic neurons; (4), small infarction (less than one-
third of the gray matter area); (5), moderate infarction (one-
thirdtoone-halfofthegraymatterarea);(6),largeinfarction
(more than half of the gray matter area). The scores of all the
sections from each spinal cord were averaged to give a ﬁnal
score for an individual mouse. All the histological studies
were performed in a blinded fashion.
2.5.NuclearProteinExtractandEMSA. Spinalcordsegments
were dissected as previously described and immediately
frozen in liquid nitrogen. Nuclear protein extraction fol-
lowed the method described by Jin et al. in our laboratory
[25]. Protein concentration was determined using a bicin-
choninic acid assay kit with boving serum albumin as the
standard (Pierce Biochemicals, Rockford, Ill, USA).
EMSA was performed using a commercial kit (Gel Shift
Assay System; Promega, Madison, Wis, USA) following theMediators of Inﬂammation 3
methods described in detail elsewhere [26]. Consensus
oligonucleotide probe (5 -AGTTGAGGGGACTTTCCCA-
GGG-3 ) was end labeled with [γ-32P]-ATP (Free Biotech.,
Beijing, China) with T4-polynucleotide kinase. Nuclear
protein(20μg)waspreincubatedinatotalvolumeof20μLin
a binding buﬀer, consisting of 10mmol/L Tris-HCl (PH 7.5),
1mmol/LMgCl2,0.5mmol/LNaCl,4%glycerol,0.5mmol/L
E D T A ,0 . 5m m o l / LD T T ,a n d2μgp o l yd I - d Cf o r2 0m i n u t e s
at room temperature. After addition of the 1μl 32P-labled
oligonucleotide probe, the incubation was continued for
20 minutes at room temperature. After adding 1μlo fg e l
loading buﬀer, the reaction was stopped, and the mixture
was resolved by electrophoresis on 4% nondenaturing poly-
acrylamide gel in 0.5×TBE buﬀer (Tris-borate-EDTA) at
390V for 1 hour at 4◦C. The gel was dried and exposed
to X-ray ﬁlm ( Fuji Hyperﬁlm, Tokyo, Japan) at −70◦C
with an intensifying screed. Levels of NF-κB DNA binding
activity were quantiﬁed by computer-assisted densitometric
analysis.
2.6. Reverse Transcriptional-Polymerase Chain Reaction
(RT-PCR). T h el e v e l so fT N F - α and MMP-9 mRNA
expression were determined by RT-PCR. Total RNA was
extracted from mouse spinal cord segments with EZgene
Tissue RNA Miniprep Kit (Biomiga, Inc., San Diego,
CA, USA) according to the manufacturer’s instructions.
The cDNA was synthesized using Reverse Transcription
System (Promega Corporation, Madison, WI, USA)
and oligo dT from 2μg of total RNA. The cDNA was
then ampliﬁed by PCR using various primer sets as
follows: TNF-α,5  -ACGGCATGGATCTCAAAGAC-3 ,a n d
5 -GGTCACTGTCCCAGCATCTT-3 ; MMP-9, 5 -CTA-
CTCTGAAGACTTGCCG-3 ,a n d5  -CCATACAGTTTATC-
CTGGTC-3 ; β-actin, 5 -AGTGTGACGTTGACATCCGTA-
3 ,a n d5  -GCCAGAGCAGTAATCTCCTTCT-3  [19, 27].
PCR products were detected by agarose gel electrophoresis
in 2% NuSieve agarose gels (FMC, USA) and visualized by
ethidium bromide staining. The intensity of the bands was
quantiﬁed using ImageJ program, and the ratios of each gene
product to β-actin product were used as indices of TNF-α
and MMP-9 mRNA expression.
2.7. Enzyme-Linked Immunosorbent Assay (ELISA). TNF-α
protein levels were both detected by ELISA at 24 hours
after SCI. Portions of spinal cord tissues were homogenized
as previously described in PBS containing 2mmol/L of
phenylmethylsulfonyl ﬂuoride (PMSF, Sigma Chemical Co.),
1mg/L pepstatin A, 1mg/L aprotinin, 1mg/L leupeptin, and
phosphate-buﬀered saline solution (pH 7.2) and centrifuged
at 12,000 ×gf o r2 0m i n u t e sa t4 ◦C. The supernatant was
then collected and total protein was determined by using
the Bradford method. TNF-α protein was quantiﬁed using
ELISA kits speciﬁc for mouse according to the manufactur-
ers’ instructions (Diaclone Research, France) and a previous
study of our laboratory [19]. The cytokine TNF-α content in
the spinal cord samples was expressed as pg per milligram
total protein.
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Figure 1:SpinalcordtissuewatercontentinshamandinjuredNrf2
(+/+)andNrf2(−/−)mice.Theﬁgureindicatesthatthespinalcord
water content was signiﬁcantly increased and was higher in Nrf2
(−/−) mice than that in Nrf2 (−/−) mice after SCI. Bars represent
mean ± S.E. (n = 6, each group). ∗P<. 01 versus genotype-
matched sham-operated mice. #P<. 05 versus treatment-matched
Nrf2 (+/+) mice.
2.8. Western Blot Analysis for MMP-9. Spinal cord tissues
were homogenized in RIPA buﬀer (1% NP40, 0.5% sodium
deoxycholate, 0.1% SDS, 1mM EDTA, 1mM EGTA, 1mM
Na3VO4, 20mM NaF, 0.5mM DTT, 1mM PMSF, and pro-
tease inhibitor cocktail in PBS pH 7.4). The homogenate was
centrifuged at 1050 ×g( 4 ◦C) for 10 min, and microsomal
fraction was subsequently centrifuged at 17,000 ×g( 4 ◦C)
for 20 minutes [28]. The supernatant was collected to
evaluate MMP-9 expression. Protein concentrations were
determined by using the Bradford method. Fifty micrograms
of the resulting cytosolic protein extracts were heat dena-
tured in Laemmli sample loading buﬀer, separated by 10%
sodium dodecyl sulfate polyacrylamide gel electrophoresis,
and electrotransferred onto a nitrocellulose membrane.
For immunoblotting, membranes were blocked with 5%
nonfat dry milk in saline buﬀer overnight, at 4◦C, and
then incubated with primary anti-MMP-9 antibody (1:500,
Calbiochem, Darmstadt, Germany) for 2 hours at room
temperature in 1×PBS, 5% w/v nonfat dry milk, and 0.1%
Tween-20 (PMT). The membranes were washed three times
for 5 minutes in PMT and the secondary incubations were
performed with horseradish peroxidase-linked antirabbit
IgG (1:5000, Jackson ImmunoResearch, West Grove, PA,
USA).Positivesignalswerevisualizedusingenhancedchemi-
luminescence (ECL; Amersham Biosciences, Bucks, United
Kingdom), and serial exposures were made to radiographic
ﬁlm (Fuji Hyperﬁlm, Tokyo, Japan). Densitometric analysis
of the blots was performed with the image analysis program
ImageJ. To ascertain that blots were loaded with equal
amounts of proteic lysates, membranes were incubated
with stripping buﬀer (100mM β-mercaptoethanol, 2% SDS,4 Mediators of Inﬂammation
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Figure 2: Inﬂuence of Nrf2 genotype on histological alterations of the spinal cord tissue 24 hours after SCI. No histologic alteration was
observed in spinal cord tissues obtained from sham-operated mice (Figure 2(a)). A signiﬁcant damage to the spinal cord from SCI mice at
theperilesional,asassessedbythepresenceofedemaaswellasanalterationofthewhitematter(Figure 2(b)).Notably,thehistologicalinjury
was severer in Nrf2 (−/−)m i c e( Figure 2(c)) than that in Nrf2 (+/+) mice (Figures 2(b) and 2(d)) at 24 hours after SCI. Bars represent mean
± S.E. (n = 6, each group). ∗P<. 01 versus genotype-matched sham-operated mice. #P<. 01 versus treatment-matched Nrf2 (+/+) mice.
wm: white matter; gm: gray matter.
62.5mM Tris-HCl, pH 6.7) at 50◦Cf o r3 0m i n u t e s ,
then washed, blocked, and reprobed overnight at 4◦C
with mouse anti-β-actin monoclonal antibody (1:5000;
Sigma).
2.9. Gelatin Zymography. We used gelatin zymography
analysis to show MMP-9 activity of spinal cord tissue
at 24 hours after SCI. Samples of spinal cord, prepared
from the epicenter, were quickly frozen at −80◦C. Each
sample was weighed and homogenized (1:4 w/v) in lysis
buﬀer containing 50mM Tris-HCl, pH 7.4, 150mM NaCl,
5mM CaCl 2,0 . 2 m MN a N 3, and 0.01% Triton. Soluble
and insoluble extracts were separated by centrifugation and
stored at −20◦C. The supernatant was collected and total
protein was determined using the Bradford method. Equal
amounts of the supernatant were analyzed by gel zymog-
raphy as described previously on 10% SDS-polyacrylamide
gels copolymerized with substrate (1mg/mL gelatin) [29].
The proteins were renatured by incubation in 2.5% Triton X-
100andthenincubatedinsubstratebuﬀer(50mMTris-HCl,
pH 8.5, 5mM CaCl2) for 24–36 hours at 37◦C to enable the
MMP-9 to cleave the gelatin. After rinsing in water, each gel
was stained with Coomassie blue for 4 hours and destained
in50%methanol.Proteolyticactivitiesweredetectedbyclear
bands indicating the lysis of the substrate. Quantiﬁcation
of MMP-9 band density was carried out using the image
analysis program ImageJ.
2.10. Statistical Analysis. Software SPSS 16.0 was used for
the statistical analyses. The results were analyzed by one-
way ANOVA followed by a Student-Newman-Keuls test for
multiple comparisons. Data are presented as mean ± SE. A
P-value less than .05 was considered signiﬁcant.
3. Results
3.1. Spinal Cord Tissue Water Content. Similar water content
of spinal cord tissue was detected in both sham-operated
Nrf2 (+/+) and Nrf2 (−/−) mice. At 48 hours after SCI,
water content of spinal cord signiﬁcantly increased in bothMediators of Inﬂammation 5
injured Nrf2 (+/+) and Nrf2 (−/−) mice compared with the
sham-operated mice, respectively. However, the pathological
change was severer in Nrf2 (−/−) mice than that in Nrf2
(+/+) mice (0.85±0.03 versus 0.78±0.02, P<. 05, Figure 1).
3.2. Histological Score. The degree of the spinal cord injury
at the perilesional area was evaluated at 24 hours after SCI.
The histological score was made by an independent observer.
Signiﬁcant damage to the spinal cord was observed in the
SCI mice than that in the sham-operated mice in both Nrf2
(+/+) and Nrf2 (−/−) mice. Notably, the histological injury
was severer in Nrf2 (−/−) mice than that in Nrf2 (+/+) mice
at 24 hours after SCI (5.3 ± 0.08 versus 4.2 ± 0.13, P<. 01,
Figure 2).
3.3. EMSA for NF-κB. NF-κB activation at 24 hours after
SCI was assessed by EMSA. As shown in Figure 3,l o wN F -
κB banding activity was detected in sham-operated mice
of both genotypes. SCI induced activation of NF-κBi n
the spinal cord in both Nrf2 (+/+) and Nrf2 (−/−)m i c e .
Nrf2 (−/−) mice showed an increased susceptibility to SCI-
induced activation of NF-κB than their wild-type Nrf2 (+/+)
counterparts (3.80±0.07 versus 2.30±0.05, P<. 01, Figures
3(a) and 3(b)).
3.4. RT-PCR for mRNA Levels of TNF-α and MMP-9. The
mRNA levels of two inﬂammatory gene products, TNF-α
and MMP-9, were measured by RT-PCR. Similar mRNA
expression levels of them were detected in the spinal cord
samples of both sham-operated groups. At 24 hours after
SCI, increased mRNA expression levels in spinal cord,
including TNF-α a n dM M P - 9 ,w e r ed e t e c t e di nb o t hi n j u r e d
Nrf2 (+/+) and Nrf2 (−/−) mice compared with the sham-
operated mice, respectively. Higher mRNA expression levels
of TNF-α were found in Nrf2 (−/−) mice than in Nrf2 (+/+)
mice (2.01±0.05 versus 0.97±0.05, P<. 01, Figures 4(a) and
4(b)).Similarly,signiﬁcantdiﬀerenceofMMP-9mRNAlevel
was also observed between Nrf2 (−/−) mice and Nrf2 (+/+)
mice (0.99±0.07 versus 0.78±0.04, P<. 01, Figures 4(c) and
4(d)).
3.5. ELISA for TNF-α. The protein expression level of
TNF-α in the spinal cord samples of both sham-operated
Nrf2 (+/+) and Nrf2 (−/−) mice was also similar. At 24 h
after SCI, higher spinal cord tissue protein expression levels
of TNF-α were detected in both injured Nrf2 (+/+) and Nrf2
(−/−) mice compared with their respective sham-operated
mice. Similarly, higher protein expression levels of TNF-α
w e r ef o u n di nN r f 2( −/−) mice than in Nrf2 (+/+) mice
(3966.60±122.67 versus 3424.04±79.66, P<. 05, Figure 5).
3.6. Western Blot Analysis for MMP-9. There is no diﬀerence
on MMP-9 expression in the spinal cord samples between
sham-operated Nrf2 (+/+) and Nrf2 (−/−) mice, as shown
by the immunoreactive band migrating at ∼92kDa. At
24 hours after SCI, signiﬁcant upregulation of MMP-9
expression levels was detected in both injured Nrf2 (+/+)
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Figure 3: NF-κB activity in the spinal cord segments of sham and
injured Nrf2 (+/+) and Nrf2 (−/−) mice. (a) Representative X-ray
ﬁlm shows NF-κB DNA binding activity by EMSA at 24 h after
SCI in sham and injured Nrf2 (+/+) and Nrf2 (−/−) mice. (b)
Quantiﬁcation of NF-κB DNA-binding activity was performed by
densitometric analysis. The ﬁgure indicates that spinal cord NF-
κB activity was signiﬁcantly increased after SCI and was greater in
Nrf2 (−/−) mice than in Nrf2 (+/+) mice. Data represents mean ±
S.E. (n = 6 per group). ∗P<. 01 versus sham control of the same
genotype. P<. 01 versus injured wild-type mice.
and Nrf2 (−/−) mice compared with their respective sham-
operated mice. Higher MMP-9 expression levels were found
in Nrf2 (−/−) mice than in Nrf2 (+/+) mice (0.98 ± 0.03
versus 0.88 ±0.02, P<. 01, Figures 6(a) and 6(b)).
3.7. Gelatin Zymography Analysis for MMP-9. The activity
of MMP-9 in spinal cord tissue was measured by gelatin
zymography analysis. In the spinal cord samples of both
sham-operated Nrf2 (+/+) and Nrf2 (−/−) mice, the activity
of MMP-9 was similar. At 24 h after SCI, higher activity of
MMP-9 was detected in both injured Nrf2 (+/+) and Nrf2
(−/−) mice compared with their respective sham-operated
mice, while the activity change was severer in Nrf2 (−/−)
mice than in Nrf2 (+/+) mice (27922.79 ± 1185.68 versus
22666.08 ±1316.41, P<. 01, Figures 7(a) and 7(b)).6 Mediators of Inﬂammation
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Figure 4: RT-PCR analysis for TNF-α and MMP-9 mRNA levels in the spinal cord samples of sham and injured Nrf2 (+/+) and Nrf2
(−/−) mice. (a) and (c) Representative agarose gel images show TNF-α and MMP-9 mRNA levels in sham and injured Nrf2 (+/+) and
Nrf2 (−/−) mice, respectively. (b) and (d) the graphs show that higher mRNA expression levels of TNF-α and MMP-9 were found in Nrf2
(−/−) mice than in Nrf2 (+/+) mice at 24 hours after SCI, respectively. Bars represent mean ± S.E. (n = 6, each group). ∗P<. 01 versus
genotype-matched sham-operated mice. #P<. 01 versus treatment-matched Nrf2 (+/+) mice.
4. Discussion
In this study, we found that the mice lacking Nrf2 function
have signiﬁcantly enhanced secondary spinal cord injury
characterized by increased spinal cord edema and severer
inﬂammatory response. Increased SCI-induced NF-κBa c t i -
vation and expression of the inﬂammatory cytokines, TNF-α
and MMP-9, were observed in the spinal cord of Nrf2 (−/−)
mice compared to Nrf2 (+/+) mice. In addition, higher level
of MMP-9 activity was found in the spinal cord of Nrf2
(−/−) mice than that in Nrf2 (+/+) mice after SCI. To our
knowledge,theﬁndingsinthisstudysuggestfortheﬁrsttime
that Nrf2 plays a protective role against SCI-induced second
spinal cord injury, possibly by limiting the inﬂammatory
response in the spinal cord after SCI.
Activation of NF-κB signaling pathway has been shown
to be central to the pathophysiology of spinal cord inﬂam-
matoryresponseinducedbySCI,andNF-κBcanbeacti vat ed
by lesion-induced oxidative stress and cytokines [6, 30]. The
functionalimportance ofNF-κB ininﬂammation isbasedon
itsabilitytoregulatethepromotersofmultipleinﬂammatory
genes [31].
Animal SCI models have shown to have inﬁltration of
inﬂammatory cells, endothelial activation and injury leading
to increased vascular permeability, edema formation, and
accumulation of inﬂammatory mediators [32]. Microvas-
cular endothelial permeability is related to focal adhesive
bond and activation of MMPs [33]. MMP-9 is produced by
neutrophils and endothelia, facilitating leukocytes diapedesis
which may be a vascular permeabilizing factor [34]. In spinal
cord injury, MMPs, including MMP-9, contribute to early
secondary pathogenesis by disrupting the blood spinal cord
barrier and promoting inﬂammation [35].
TNF-α is a major initiator of inﬂammation and is
released early after an inﬂammatory stimulus. It is upregu-
lated immediately after SCI and it can enhance vascular per-
meability. Evidence has been provided that TNF-α induces
the production of matrix metalloproteinase MMP-9 [36].Mediators of Inﬂammation 7
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Figure 5: Protein expression levels of TNF-α in spinal cord samples
of sham and injured Nrf2 (+/+) and Nrf2 (−/−)m i c e .T h eﬁ g u r e
indicates that spinal cord contents of TNF-α were signiﬁcantly
increased and were higher in Nrf2 (−/−) mice than in Nrf2 (+/+)
mice at 24 hours after SCI. Bars represent mean ± S.E. (n = 6, each
group). ∗P<. 01 versus genotype-matched sham-operated mice.
#P<. 05 versus treatment-matched Nrf2 (+/+) mice.
There is evidence that TNF-α also plays an important role
in the recruitment of inﬂammatory and immune cells to
the injured site. Moreover, the inﬁltration of immune and
inﬂammatory cell to SCI sites is a major contributor to
secondary degeneration [37]. Consistent with other studies,
we show that TNF-α and MMP-9 were also upregulated
during SCI, spinal cord water content at the injury site
increased at 2 days after SCI, and signiﬁcant damage to
the spinal cord was observed in the tissue from SCI mice
[9, 22, 24].
Nrf2 has been reported to be the key regulator of the
expression of a group of antioxidant and detoxiﬁcation
enzymes and is considered to play an important role
in modulating inﬂammation in a variety of experimental
models [38, 39]. Also, the Nrf2 signaling pathway has been
shown to modulate NF-κB activation and expression of NF-
κB-dependent genes including MMP-9 [40]. In our past
studies, the results suggested that Nrf2 plays an important
role in protecting TBI-induced secondary brain injury,
possibly by limiting the cerebral upregulation of NF-κB
activity, proinﬂammatory cytokine after TBI [25]. Recently,
Pomeshchik et al. showed that SCI could induce Nrf2-
ARE pathway activation in spinal cord [20], just as our
laboratoryhasfound(datanotshown).Alsoinvitro,phaseII
enzymeinducerscanpromotetheexpressionofantioxidative
enzymes through Nrf2 and show neuroprotective potential
on motor neuron survival in traumatic spinal cord injury
[41]. In the present study, Nrf2 (−/−)m i c ew e r es h o w nt o
have severer spinal cord edema, more NF-κBa c t i v i t y ,m o r e
inﬂammatory cytokine TNF-α, and MMP-9 expression in
spinal cord after SCI compared with their wild-type Nrf2
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Figure 6:MMP-9expressionbyWesternblotanalysisinspinalcord
homogenates from sham and injured Nrf2 (+/+) and Nrf2 (−/−)
mice. (a) Representative X-ray ﬁlm shows MMP-9 expression by
Westernblotanalysisat24hoursafterSCIinshamandinjuredNrf2
(+/+) and Nrf2 (−/−) mice. (b) The ﬁgure indicates that higher
MMP-9 expression levels were found in Nrf2 (−/−) mice than in
Nrf2 (+/+) mice at 24 hours after SCI. Bars represent mean ± S.E.
(n = 6, each group). ∗P<. 01 versus sham control of the same
genotype. #P<. 01 versus injured wild-type mice.
(+/+) counterparts. Taken together, these studies showed
that Nrf2 may play an important protective role in limiting
the spinal cord inﬂammatory response after SCI.
Although numerous in vivo studies have reported that
Nrf2 plays a critical role in counteracting the inﬂamma-
tion in a variety of experimental models [15, 16, 25],
the precise mechanism underlying this network is still
unclear. Several lines of evidence indicate that Nrf2 interferes
with inﬂammatory signaling pathways by inhibiting NF-
κB activation through the maintenance of cellular redox
status. Oxidative stress from reactive oxygen species (ROS)
was considered as a major pathway of secondary injury
in SCI [42]. Activation of the NF-κB signaling pathway
has been shown to be responsive to excess ROS and is
important in the generation of inﬂammation [39]. Nrf2
has been shown to play an important role in limiting ROS8 Mediators of Inﬂammation
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Figure 7: Gelatin zymography analysis for the activity of MMP-
9 in spinal cord tissue of sham and injured Nrf2 (+/+) and Nrf2
(−/−) mice. (a) Representative gelatin images show the activity of
MMP-9 in sham and injured Nrf2 (+/+) and Nrf2 (−/−)m i c e .
(b) The graphs show that higher activity of MMP-9 was found in
Nrf2 (−/−) mice than in Nrf2 (+/+) mice at 24 hours after SCI.
Bars represent mean ± S.E. (n = 6, each group). ∗P<. 01 versus
genotype-matched sham-operated mice. #P<. 01 versus treatment-
matched Nrf2 (+/+) mice.
levels and thereby aﬀects the redox-sensitive NF-κB signaling
pathwayinvolvedininﬂammation[14,40].Augmentationof
cellular antioxidative or detoxiﬁcation systems via activation
ofNrf2-regulatedenzymesresultsindecreasedinﬂammatory
cytokine production via inactivation of NF-κB[ 12]. This
constitutes a possible anti-inﬂammatory mechanism for the
attenuated inﬂammatory response and tissue damage seen in
spinal cord from Nrf2 (+/+) mice but not Nrf2 (−/−)m i c e
after SCI. Additional research is necessary to elucidate the
entire mechanisms involved in these complicated networks.
5. Conclusions
In conclusion, the present study showed that Nrf2 (−/−)
micearemoresusceptibletoSCI-inducedspinalcordedema,
NF-κBactivity,inﬂammatoryTNF-αproduction,andMMP-
9 expression, which then contributed to exacerbated spinal
cord injury after SCI. These ﬁndings raise the possibility that
Nrf2 might be a new therapeutic target for the treatment of
SCI.
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